RecruitingNot ApplicableNCT05396638
Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder
Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents
Sponsor
University of Colorado, Denver
Enrollment
30 participants
Start Date
Oct 13, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This project seeks to learn more about the effects of cannabis use on the endocannabinoid system and endogenous opioid systems in adolescents to address a fundamental gap in knowledge and identify biomarkers that may help distinguish youth who relapse from youth who remain sober.
Eligibility
Min Age: 14 YearsMax Age: 25 Years
Inclusion Criteria2
- 14 to 25 years of age.
- Use cannabis at least twice a week for the past month.
Exclusion Criteria9
- Refusal of valid written consent,
- Current psychosis,
- Obvious intoxication,
- Current risk of suicide,
- Violence sufficiently great to interfere with evaluation or to endanger evaluators,
- Obvious intellectual deficiency as noted during the informed consent process, or inability of patient or family to comply with the study protocol.
- Use of other illicit drugs in the past 90 days by self-report or detected by urine drug test.
- Use of opioid medications for medical or recreational purposes currently or within the past 90 days.
- Does not have access to an Internet connected devise or cannot use Zoom.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALContingency Management
Participants will be paid for abstinence at each study visit.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05396638
Related Trials
Cannabis-Tobacco Co-Use Treatment Study
NCT068831621 location
Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis
NCT070018782 locations
Neuroimaging of Adolescent Cannabis Use Treatment
NCT073405541 location
Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
NCT070116151 location
Study of Oral Fluid Testing Approach
NCT068912351 location